Santen Pharmaceutical Co Ltd banner

Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 716 JPY 0.09% Market Closed
Market Cap: ¥553B

Wall Street
Price Targets

Price Targets Summary
Santen Pharmaceutical Co Ltd

Wall Street analysts forecast Santen Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Santen Pharmaceutical Co Ltd is 2 113.95 JPY with a low forecast of 1 717 JPY and a high forecast of 2 730 JPY.

Lowest
Price Target
1 717 JPY
0% Upside
Average
Price Target
2 113.95 JPY
23% Upside
Highest
Price Target
2 730 JPY
59% Upside
Santen Pharmaceutical Co Ltd Competitors:
Price Targets
SONO
Sonos Inc
27% Upside
UUU
3U Holding AG
95% Upside
SMG
Scotts Miracle-Gro Co
5% Upside

Revenue
Forecast

8% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
8% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 1%.

Operating Income
Forecast

5% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
5% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

For the last 13 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's operating income is 5%. The projected CAGR for the next 2 years is 11%.

Net Income
Forecast

6% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
16%
Average Beat
6% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
16%
Average Beat

For the last 13 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 7%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Santen Pharmaceutical Co Ltd's stock price target?
Price Target
2 113.95 JPY

According to Wall Street analysts, the average 1-year price target for Santen Pharmaceutical Co Ltd is 2 113.95 JPY with a low forecast of 1 717 JPY and a high forecast of 2 730 JPY.

What is Santen Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 1%.

What is Santen Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's operating income is 5%. The projected CAGR for the next 2 years is 11%.

What is Santen Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
7%

For the last 13 years the compound annual growth rate for Santen Pharmaceutical Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 7%.

Back to Top